Literature DB >> 7091887

Aspergillus terreus, a pathogen capable of causing infective endocarditis, Pulmonary mycetoma, and allergic bronchopulmonary aspergillosis.

M N Laham, J L Carpenter.   

Abstract

Aspergillus terreus is a rarely reported pathogen in humans, Recovery of this organism from the sputum may therefore be discounted as representing contamination this report describes 3 patients--1 with allergic bronchopulmonary aspergillosis (ABPA), 1 with aspergilloma, and 1 with infective endocarditis-- in whom A. terreus was proved to be the etiologic organism. Together, these 3 cases span the spectrum of disease usually associated with A. fumigatus. Detection of serum precipitins against Aspergillus is essential to a diagnosis of both ABPA and aspergilloma. In our 2 patients with these syndromes, serum precipitins were specific for A. terreus ane did not cross-react with A. fumigatus or mixed Aspergillus antigens. This finding suggests that screening of serum for precipitins were specific for A. terreus and did not cross-react with A. fumigatus or mixed Aspergillus antigens. This finding suggests that screening of serum for precipitins should be carried out with A. terreus antigen in patients suspected of harboring this organism.

Entities:  

Mesh:

Year:  1982        PMID: 7091887     DOI: 10.1164/arrd.1982.125.6.769

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Pulmonary aspergillosis due to Aspergillus terreus combined with staphylococcal pneumonia and hepatic candidiasis.

Authors:  M Kimura; S Udagawa; A Shoji; H Kume; M Iimori; T Satou; S Hashimoto
Journal:  Mycopathologia       Date:  1990-07       Impact factor: 2.574

Review 2.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Clinical reactions to Aspergillus niger in a biotechnology plant: an eight year follow up.

Authors:  A Seaton; D Wales
Journal:  Occup Environ Med       Date:  1994-01       Impact factor: 4.402

4.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Authors:  D A Sutton; S E Sanche; S G Revankar; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

5.  Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus.

Authors:  Z U Khan; M Kortom; R Marouf; R Chandy; M G Rinaldi; D A Sutton
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 6.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.

Authors:  Sanjay H Chotirmall; Maria Teresa Martin-Gomez
Journal:  Mycopathologia       Date:  2017-05-17       Impact factor: 2.574

7.  Endocarditis and aortal embolization caused by Aspergillus terreus in a patient with acute lymphoblastic leukemia in remission: diagnosis by peripheral-blood culture.

Authors:  G Schett; B Casati; B Willinger; G Weinländer; T Binder; F Grabenwöger; W Sperr; K Geissler; U Jäger
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Aspergillus terreus causing invasive pulmonary aspergillosis with air-crescent sign.

Authors:  S W Chang; T E King
Journal:  J Natl Med Assoc       Date:  1986-03       Impact factor: 1.798

Review 9.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Authors:  Ibrahim Ahmed Janahi; Abdul Rehman; Amal Rashid Al-Naimi
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

10.  Emergence of persistent Aspergillus terreus colonisation in a child with cystic fibrosis.

Authors:  Katie Dunne; Anna-Rose Prior; Kate Murphy; Niall Wall; Geraldine Leen; Thomas R Rogers; Basil Elnazir; Peter Greally; Julie Renwick; Philip Murphy
Journal:  Med Mycol Case Rep       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.